146 related articles for article (PubMed ID: 18650093)
1. Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4.
Jenkins PR; Wilson J; Emmerson D; Garcia MD; Smith MR; Gray SJ; Britton RG; Mahale S; Chaudhuri B
Bioorg Med Chem; 2008 Aug; 16(16):7728-39. PubMed ID: 18650093
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, crystal structure and biological activity of beta-carboline based selective CDK4-cyclin D1 inhibitors.
García MD; Wilson AJ; Emmerson DP; Jenkins PR; Mahale S; Chaudhuri B
Org Biomol Chem; 2006 Dec; 4(24):4478-84. PubMed ID: 17268643
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin.
Aubry C; Wilson AJ; Jenkins PR; Mahale S; Chaudhuri B; Maréchal JD; Sutcliffe MJ
Org Biomol Chem; 2006 Mar; 4(5):787-801. PubMed ID: 16493461
[TBL] [Abstract][Full Text] [Related]
4. Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1.
Aubry C; Wilson AJ; Emmerson D; Murphy E; Chan YY; Dickens MP; García MD; Jenkins PR; Mahale S; Chaudhuri B
Bioorg Med Chem; 2009 Aug; 17(16):6073-84. PubMed ID: 19632122
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and biological activity of a tryptamine and beta-carboline series of bases.
Begum S; Usmani SB; Siddiqui BS; Saeed SA; Farnaz S; Khan KA; Khan SA; Khalid SM; Zia A
Arzneimittelforschung; 1996 Dec; 46(12):1163-8. PubMed ID: 9006793
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of β-carboline derivatives as novel inhibitors targeting B-Raf kinase.
Xin B; Tang W; Wang Y; Lin G; Liu H; Jiao Y; Zhu Y; Yuan H; Chen Y; Lu T
Bioorg Med Chem Lett; 2012 Jul; 22(14):4783-6. PubMed ID: 22704238
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: synthesis, biological evaluation, and structure-activity relationships.
Horiuchi T; Chiba J; Uoto K; Soga T
Bioorg Med Chem Lett; 2009 Jan; 19(2):305-8. PubMed ID: 19091560
[TBL] [Abstract][Full Text] [Related]
8. Domino Heck-aza-Michael reactions: efficient access to 1-substituted tetrahydro-beta-carbolines.
Priebbenow DL; Henderson LC; Pfeffer FM; Stewart SG
J Org Chem; 2010 Mar; 75(5):1787-90. PubMed ID: 20131765
[TBL] [Abstract][Full Text] [Related]
9. Analytical characterisation of the routes by thermolytic decarboxylation from tryptophan to tryptamine using ketone catalysts, resulting in tetrahydro-beta-carboline formation.
Brandt SD; Mansell D; Freeman S; Fleet IA; Alder JF
J Pharm Biomed Anal; 2006 Jun; 41(3):872-82. PubMed ID: 16569488
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin.
Mahale S; Aubry C; Jenkins PR; Maréchal JD; Sutcliffe MJ; Chaudhuri B
Bioorg Chem; 2006 Oct; 34(5):287-97. PubMed ID: 16904725
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic evaluation of 1-carboxamide and 1-amino side chain substituted β-carbolines.
Ma C; Cao R; Shi B; Zhou X; Ma Q; Sun J; Guo L; Yi W; Chen Z; Song H
Eur J Med Chem; 2010 Nov; 45(11):5513-9. PubMed ID: 20846759
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1-CDK4: synthesis, biological evaluation and structure-activity relationships. Part 2.
Horiuchi T; Nagata M; Kitagawa M; Akahane K; Uoto K
Bioorg Med Chem; 2009 Dec; 17(23):7850-60. PubMed ID: 19889545
[TBL] [Abstract][Full Text] [Related]
13. Discovery of cyclin-dependent kinase inhibitor, CR229, using structurebased drug screening.
Kim MK; Min J; Choi BY; Lim H; Cho YH; Lee CH
J Microbiol Biotechnol; 2007 Oct; 17(10):1712-6. PubMed ID: 18156791
[TBL] [Abstract][Full Text] [Related]
14. Syntheses of tetrahydro-beta-carbolines via a tandem hydroformylation-Pictet-Spengler reaction. Scope and limitations.
Bondzic BP; Eilbracht P
Org Biomol Chem; 2008 Nov; 6(21):4059-63. PubMed ID: 18931815
[TBL] [Abstract][Full Text] [Related]
15. Identification and occurrence of tryptamine- and tryptophan-derived tetrahydro-beta-carbolines in commercial sausages.
Herraiz T; Papavergou E
J Agric Food Chem; 2004 May; 52(9):2652-8. PubMed ID: 15113173
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of β-carboline 3-(substituted-carbohydrazide) derivatives.
Barbosa VA; Formagio AS; Savariz FC; Foglio MA; Spindola HM; de Carvalho JE; Meyer E; Sarragiotto MH
Bioorg Med Chem; 2011 Nov; 19(21):6400-8. PubMed ID: 21944971
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.
Minehira D; Takeda D; Urata H; Kato A; Adachi I; Wang X; Matsuya Y; Sugimoto K; Takemura M; Endo S; Matsunaga T; Hara A; Koseki J; Narukawa K; Hirono S; Toyooka N
Bioorg Med Chem; 2012 Jan; 20(1):356-67. PubMed ID: 22104435
[TBL] [Abstract][Full Text] [Related]
18. Fascaplysin as a specific inhibitor for CDK4: insights from molecular modelling.
Shafiq MI; Steinbrecher T; Schmid R
PLoS One; 2012; 7(8):e42612. PubMed ID: 22905154
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro cytotoxic evaluation of 1,3-bisubstituted and 1,3,9-trisubstituted beta-carboline derivatives.
Cao R; Peng W; Chen H; Hou X; Guan H; Chen Q; Ma Y; Xu A
Eur J Med Chem; 2005 Mar; 40(3):249-57. PubMed ID: 15725494
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors.
Koehler L; Graf F; Bergmann R; Steinbach J; Pietzsch J; Wuest F
Eur J Med Chem; 2010 Feb; 45(2):727-37. PubMed ID: 19954867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
